Our Company / Alfasigma at glance

Pharmaceuticals
with passion

Alfasigma is one of the top 5 pharmaceutical companies in Italy, with a turnover in 2019 of more than 1 billion euros. It’s a private company with 75% owned by the family of the founder and 25% by two funds. The Alfasigma legacy is firmly anchored in a long lasting heritage of innovation and success, beginning in 1948 in Bologna (Italy) thanks to Marino Golinelli, the 100 years old philanthropist.

From the beginning Alfasigma has always persecuted a twofold strategy:
– internally, a strong focus on Research & Development and Manufacturing around some proprietary
molecules, some of which represent more than 50% of the sales;
– externally, developing a robust strategy of mergers and acquisitions of other Italian and international companies (Sigma Tau, Pamlabs).
Currently Alfasigma has more than 3.000 employees worldwide, 17 direct branches and – through top
distributors – its presence spreads over more than 70 countries.

Read More

Company Profile
PDF - 7.4 MB

Geographic coverage

Subsidiaries

Distributors

70

Distributors

17

Subsidiaries

Belgium
China
Czech Republic
France
India
Italy
Mexico
Netherlands
Poland

Portugal 
Romania
Russia
Slovak Republic
Spain
Switzerland
Tunisia
Usa

Turnover

€ 1,05

billions in 2019

0%

5 proprietary molecules
Rifaximin, Sulodexide, Carnitine, L-Methylfolate, Parnaparin

Contract Manufacturing – Business Unit

Alongside its traditional business, the company is also playing a leading role supplying to other multinational and Italian pharmaceutical companies thanks to its Contract Manufacturing division, which has been on a constant growth trajectory since 2017 with a CAGR (Compound Annual Growth Rate) of 10.2%.

2017

2018

2019

2

R&D centers

5

Manufacturing plants

25

Offices worldwide

Headcount

3000

Workforce

51,4%

Male

48,6%

Female

1800

Domestic

1200

International

Workforce
(out of Italy)

USA 26,3% Spain 13,5% 9,4% Russia 12,5% China 38,4% Rest of the world

Read More

Alfasigma was established in 2015 from the merging of two big companies – Alfa Wassermann and Sigma-Tau – both with over 60 years of history behind them.
In 2019 Alfasigma adopted a new Leadership Model that prescribes five preferred behaviors to be put into practice daily.
Social contract between the company and internal and external stakeholders having a normative value for the entire Alfasigma system.